Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far?
Crossref DOI link: https://doi.org/10.1007/s00405-020-06003-w
Published Online: 2020-05-01
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Waissbluth, Sofia http://orcid.org/0000-0002-6884-968X
Text and Data Mining valid from 2020-05-01
Version of Record valid from 2020-05-01
Article History
Received: 17 February 2020
Accepted: 20 April 2020
First Online: 1 May 2020
Compliance with ethical standards
:
: The author declares that she has no conflict of interest.